Haptena
1 employees on LinkedIn · 1 known investors
Find your way into Haptena
Haptena Therapeutics is a biotech company developing next-generation immunotherapies for oncogene-driven, genetically defined cancers, starting with KRAS-driven tumors. It combines targeted therapy precision with immune-based approaches to create more durable treatment options for patients with difficult-to-treat cancers.
Founders & leadership
CA
Chiara AmbrogioCo-founder
RC
Roberto ChiarleCo-founder
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountseed funding roundDec 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Haptena do?
- Haptena Therapeutics is a biotech company developing next-generation immunotherapies for oncogene-driven, genetically defined cancers, starting with KRAS-driven tumors. It combines targeted therapy precision with immune-based approaches to create more durable treatment options for patients with difficult-to-treat cancers.
- Who founded Haptena?
- Haptena was founded by Chiara Ambrogio, Roberto Chiarle.
- Who are Haptena's investors?
- Haptena's investors include Claris Ventures.